Rchr
J-GLOBAL ID：200901091941335423
Update date: Aug. 21, 2024
Iizuka Toshihiko
イイヅカ トシヒコ | Iizuka Toshihiko
Affiliation and department：
Research field (2)：
Human pathology
, Tumor biology
Research theme for competitive and other funds (2)：
- 2013 - 2017 Expression of long noncoding RNA in lung adenocarcinoma
- 2001 - 2002 肺胞上皮細胞の変移の分子機構の解明
Papers (18)：
-
HIROTAKA FUCHIZAWA, KIYOHIRO ANDO, NORIKO MOTOI, TOSHIHIKO IIZUKA, MASAHARU INOUE, KOUKI MITANI, YUTA SANO, HISANORI TAKENOBU, MASAYUKI HARUTA, RITSUKO ONUKI, et al. STAT3 Contributes a Favorable Response to Pembrolizumab Through IFN-γ-induced Apoptosis in Urothelial Cancer. Anticancer Research. 2024. 44. 5. 1925-1930
-
Kiyohiro Ando, Ryo Kurashina, Noriko Motoi, Toshihiko Iizuka, Masaharu Inoue, Riko Maruyama, Kouki Mitani, Hisanori Takenobu, Masayuki Haruta, Ritsuko Onuki, et al. Positive regulatory loop of platelet-derived growth factor DD-induced STAT3 activation is associated with poor prognosis in advanced urothelial carcinoma. Biochemical and Biophysical Research Communications. 2023. 676. 165-170
-
RYO KURASHINA, KIYOHIRO ANDO, MASAHARU INOUE, KEITA IZUMI, RIKO MARUYAMA, KOUKI MITANI, HISANORI TAKENOBU, MASAYUKI HARUTA, TOSHIHIKO IIZUKA, TAKEHIKO KAMIJO, et al. Platelet-to-Lymphocyte Ratio Predicts the Efficacy of Pembrolizumab in Patients With Urothelial Carcinoma. Anticancer Research. 2022. 42. 2. 1131-1136
-
Toshihiko Iizuka, Hiroko Nagano, Kimie Nomura, Miyako Hiramatsu, Noriko Motoi, Mingyon Mun, Yuichi Ishikawa. The combined use of long non-coding RNA HOTAIR and polycomb group protein EZH2 as a prognostic marker of lung adenocarcinoma. Cancer Treatment and Research Communications. 2022. 31. 100541-100541
-
Kumiko Umemoto, Yasushi Kojima, Naoyoshi Nagata, Chizu Yokoi, Toshiyuki Sakurai, Masao Kobayakawa, Toshihiko Iizuka, Toru Igari, Mikio Yanase, Junichi Akiyama. Cytomegalovirus esophagitis developing during chemoradiotherapy for esophageal cancer: two case reports. Journal of Medical Case Reports. 2016. 10. 1
ｍore...
MISC (34)：
-
Toshihiko Iizuka, Ayataka Ishikawa, Noriko Motoi, Hiroaki Kanda, Yukio Kageyama. Usefulness of polycomb protein EZH2 immunostaining in the diagnosis of urothelial carcinoma in situ. 2024
-
元井紀子, 飯塚利彦, 西村ゆう. 肺癌WHO分類:2021年第5版における改定点. 診断病理. 2022. 39. 3. p194
-
飯塚利彦, 伊藤以知郎, 河田卓也, 亀谷徹, 杉野隆, 中島孝. 肺生検で診断された腎盂原発Invasive urothelial carcinoma with chordoid featuresの肺転移の1例. 第107回日本病理学会総会(札幌). 2018
-
飯塚利彦, 長野裕子, 野村紀美恵, 石川雄一. 肺腺癌および周囲肺組織における長鎖非コードRNA MALAT-1の発現. 第105回日本病理学会総会(仙台). 2016
-
飯塚利彦, 長野裕子, 野村紀美恵, 元井紀子, 石川雄一. 肺腺癌での長鎖非コードRNA HOTAIRおよびポリコーム遺伝子EZH2の発現-組織像、予後との関連. 第104回日本病理学会総会(名古屋). 2015
ｍore...
Education (2)：
- 1995 - 2000 Tokyo Medical and Dental University
- 1986 - 1992 Tokyo Medical and Dental University
Professional career (1)：
- Ph.D. (Tokyo Medical and Dental University)
Association Membership(s) (3)：
日本癌学会
, 日本臨床細胞学会
, 日本病理学会
